...
首页> 外文期刊>Surgery >Total thyroidectomy for Graves' disease: Compliance with American Thyroid Association guidelines may not always be necessary
【24h】

Total thyroidectomy for Graves' disease: Compliance with American Thyroid Association guidelines may not always be necessary

机译:用于格雷夫斯病的全甲状腺切除术:不一定总是需要遵守美国甲状腺协会的指南

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Total thyroidectomy (TT) is the preferred operative approach to Graves' disease. Current guidelines of the American Thyroid Association call for the administration of potassium iodide (KI) and achievement of euthyroid state before operation. Small numbers and a mixture of operative approaches spanning several decades hinder previous operative series. We present the outcomes for TT at a single high-volume center. Methods: A retrospective cohort study was conducted on 165 patients undergoing TT for Graves' disease from July 2007 to May 2012. Results: Mean age was 43 years (range, 17-78), and 128 patients (78%) were female. A total of 95% of patients were on methimazole or propylthiouracil, and 42% remained hyperthyroid at time of TT. Only 3 (2%) patients received KI. Mean operative time was 132 minutes (range, 59-271). Mean gland size and blood loss were 41 g (range, 8-180) and 55 mL (range, 10-1050), respectively. No patient developed thyroid storm. Median follow-up was 7.5 months. Temporary and permanent hypocalcemia developed in 51 (31%) and 2 patients (1.2%), respectively. Temporary and permanent recurrent laryngeal nerve paresis occurred in 12 (7%) and one (0.6%) patient, respectively. Sixty-one (37%) patients experienced at least one complication. On multivariate analysis, patient age younger than 45 years (odds ratio 2.93, 95% confidence interval 1.39-6.19) and obesity (odds ratio 2.11, 95% confidence interval 1.00-4.43) were associated with the occurrence of complications. Conclusion: This high-volume surgeon experience demonstrates no appreciable detriment to patient outcomes when recommendations of the American Thyroid Association for routine use of KI and euthyroid state before thyroidectomy are not met. Transient hypocalcemia and hoarseness are frequent complications of TT for Graves' disease, resolving within 6 months in most patients. Age younger than 45 years and obesity are risk factors for postoperative complications.
机译:背景:全甲状腺切除术(TT)是治疗格雷夫斯病的首选手术方法。美国甲状腺协会的现行指南要求在手术前给予碘化钾(KI)并达到甲状腺正常状态。跨越数十年的少量和混合手术方式阻碍了先前的手术系列。我们在一个高容量的中心展示TT的结果。方法:从2007年7月至2012年5月,对165例因Graves病接受TT的患者进行了回顾性队列研究。结果:平均年龄为43岁(范围17-78岁),女性128例(78%)。共有95%的患者服用甲他唑或丙基硫氧嘧啶,而TT时仍有42%的患者甲亢。只有3(2%)患者接受了KI。平均手术时间为132分钟(范围59-271)。平均腺体大小和失血量分别为41 g(8-180范围)和55 mL(10-1050范围)。没有患者发生甲状腺风暴。中位随访时间为7.5个月。临时和永久性低钙血症分别发生在51名(31%)和2名患者(1.2%)中。临时和永久性喉返神经麻痹发生在12例(7%)和1例(0.6%)患者中。六十一(37%)名患者经历了至少一种并发症。在多变量分析中,年龄小于45岁(赔率2.93,95%置信区间1.39-6.19)和肥胖症(赔率2.11,95%置信区间1.00-4.43)与并发症的发生相关。结论:当未达到美国甲状腺协会对甲状腺手术前常规使用KI和正常甲状腺状态的建议时,这种大量的外科医生经验表明对患者的预后无明显损害。短暂性低血钙和声音嘶哑是TT治疗Graves病的常见并发症,大多数患者可在6个月内解决。年龄小于45岁和肥胖是术后并发症的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号